BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study.
Munkhaugen J, Ruddox V, Halvorsen S, Dammen T, Fagerland MW, Hernæs KH, Vethe NT, Prescott E, Jensen SE, Rødevand O, Jortveit J, Bendz B, Schirmer H, Køber L, Bøtker HE, Larsen AI, Vikenes K, Steigen T, Wiseth R, Pedersen T, Edvardsen T, Otterstad JE, Atar D.
Munkhaugen J, et al. Among authors: rodevand o.
Am Heart J. 2019 Feb;208:37-46. doi: 10.1016/j.ahj.2018.10.005. Epub 2018 Oct 25.
Am Heart J. 2019.
PMID: 30530121
Clinical Trial.